Bionano Genomics (BNGO) said Thursday it is offering 9.88 million common shares and series C and series D warrants, each to purchase additional 9.88 million shares, in a registered direct offering for $3 million.
Shares and warrants will be sold separately, with both series having an exercise price of $0.3039 per share, the company said in a regulatory filing.
The series C warrants expire five years after stockholder approval, while the series D warrants expire 18 months after approval, Bionano said.
Bionano plans to use the net proceeds, together with its existing cash and cash equivalents and available-for-sale securities, for general corporate purposes.
Bionano shares fell more than 11% in recent trading.
Price: 0.30, Change: -0.04, Percent Change: -11.30
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.